Edmund J. Pezalla, MD, MPH

Exploring how health plans and hemophilia treatment centers can better work together to deliver high-quality care and manage costs associated with hemophilia.

As the number of both generic and specialized products continues to increase, we must seek a clear method for defining value in healthcare delivery.

The President of the Pharmacy & Therapeutics Society reviews the vision and goals for 2009 and announces its selection of The American Journal of Pharmacy Benefits as the Society's new official publication.

In the President�s Address, Dr Pezalla observed that any healthcare reform will require the hard work of managing both the cost and quality of care.

The Society seeks input from both individuals and organizations as it creates a new environment of data-driven P&T best practices.

This commentary encourages P&T committee members to be champions for assimilating new findings into medical practice and translating research into real outcomes.